Skip to main navigation Skip to search Skip to main content

Cognitive Enhancers and Mental Impairment: Emerging Ethical Issues

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Neurotechnology has been discussed in the literature as either treatment or enhancement, although a clear-delineation between the two has not been drawn. This chapter explores a third use of neurotechnology that neither fits squarely into the category of treatment, nor carries some of the moral hesitancies of pure enhancement in healthy persons. This third category, referred to as enhancement-2, is the enhancement of those persons who have baseline cognitive impairments related to a mental disability, but are relatively healthy otherwise. Considering that cognitively impaired healthy individuals could improve functionality in "major life activities" and enhance their overall quality of life, the use of cognitive enhancers can be morally justified through careful analysis on a case-specific basis. A careful examination of the risks involved in cognitive enhancement procedures for particular individuals, in consultation with their legal representative, warrants a prudent acceptance of enhancement technologies for the mentally impaired.

Original languageEnglish (US)
Title of host publicationRosenberg's Molecular and Genetic Basis of Neurological and Psychiatric Disease
Subtitle of host publicationFifth Edition
PublisherElsevier Inc.
Pages119-126
Number of pages8
ISBN (Electronic)9780124105294
ISBN (Print)9780124105492
DOIs
StatePublished - Nov 13 2014
Externally publishedYes

Keywords

  • Cognitive enhancers
  • Mental impairment
  • Neurostimulation
  • Personal identity
  • Psychopharmacology

ASJC Scopus subject areas

  • General Medicine

Fingerprint

Dive into the research topics of 'Cognitive Enhancers and Mental Impairment: Emerging Ethical Issues'. Together they form a unique fingerprint.

Cite this